Cholinesterase inhibitor therapy stabilizes symptoms of Alzheimer disease.
about
Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomised, placebo controlled trialSalvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomized and placebo-controlled trial.Novel nootropic drug sunifiram enhances hippocampal synaptic efficacy via glycine-binding site of N-methyl-D-aspartate receptor.Undifferentiated and differentiated PC12 cells protected by huprines against injury induced by hydrogen peroxideA Novel Application of Multiscale Entropy in Electroencephalography to Predict the Efficacy of Acetylcholinesterase Inhibitor in Alzheimer's Disease.Herbal medicine in the treatment of Alzheimer's disease.Nicotinic receptors in neurodegeneration.Comparison of persistence rates of acetylcholine-esterase inhibitors in a state Medicaid program.The prediction of response to galantamine treatment in patients with mild to moderate Alzheimer's disease.Cholinergic modulation of the hippocampal region and memory function.Predicting the neural effect of switching from donepezil to galantamine based on single-photon emission computed tomography findings in patients with Alzheimer's disease.Antiamnesic Effects of Walnuts Consumption on Scopolamine-Induced Memory Impairments in RatsThe neuroprotective effect of curcumin and Nigella sativa oil against oxidative stress in the pilocarpine model of epilepsy: a comparison with valproate.Walnut supplementation reverses the scopolamine-induced memory impairment by restoration of cholinergic function via mitigating oxidative stress in rats: a potential therapeutic intervention for age related neurodegenerative disorders.Sigma-1 receptor stimulation by dehydroepiandrosterone ameliorates cognitive impairment through activation of CaM kinase II, protein kinase C and extracellular signal-regulated kinase in olfactory bulbectomized mice.The Neuropharmacological Basis for the Use of Memantine in the Treatment of Alzheimer's Disease
P2860
Q24671886-FEFEA480-0118-44D6-9554-D6FDA1975C74Q33964539-65D2AF6A-21E9-47CE-9053-A8DD69C2F889Q34348499-2CF5CC2D-75CA-4C57-A3DB-361C6E97737EQ35004992-8E02F610-8CDA-474A-82FD-DAA54E8E458EQ35668990-500977F8-B1A1-4D8F-97EE-4F52F18D5413Q36458304-D52F4A46-FC35-450A-B8A2-6C5418001492Q36828916-BE7F5133-AB89-4251-BF03-54491D30645FQ37405505-E3C9EC3B-C956-48A0-A1CE-B307013356F3Q37691138-BA240C8B-F8DA-47ED-B4C8-5E5E86D4EC0BQ38372480-738FCC00-A298-4D54-AA91-C1585569E84EQ40793617-AE152BA6-C83B-4B0B-BDE5-13BD9C6A3725Q41835947-AA9B11B5-43D0-4C8A-951D-F9C8E3E24C5AQ44031099-6B207BC1-1BDF-4844-8CB5-3E4DD9C25E32Q45069944-C00B5D80-8749-443F-BAEE-E92D23D1C2FAQ51015549-430F1BD9-C5A0-43EA-A5F8-033A02D754EAQ56484985-5783298E-72BE-4365-A98A-C703E489AE28
P2860
Cholinesterase inhibitor therapy stabilizes symptoms of Alzheimer disease.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Cholinesterase inhibitor therapy stabilizes symptoms of Alzheimer disease.
@ast
Cholinesterase inhibitor therapy stabilizes symptoms of Alzheimer disease.
@en
type
label
Cholinesterase inhibitor therapy stabilizes symptoms of Alzheimer disease.
@ast
Cholinesterase inhibitor therapy stabilizes symptoms of Alzheimer disease.
@en
prefLabel
Cholinesterase inhibitor therapy stabilizes symptoms of Alzheimer disease.
@ast
Cholinesterase inhibitor therapy stabilizes symptoms of Alzheimer disease.
@en
P1476
Cholinesterase inhibitor therapy stabilizes symptoms of Alzheimer disease.
@en
P2093
Giacobini E
P356
10.1097/00002093-200000001-00002
P407
P478
14 Suppl 1
P577
2000-01-01T00:00:00Z